Results 181 to 190 of about 690,294 (320)

Hemodynamics at Rest and during Exercise in Combined Aortic Stenosis and Insufficiency [PDF]

, 1972
Philip O. Ettinger, Martin J. Frank, Gilbert E. Levinson   +2 more
openalex   +1 more source

The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approaches

ESC Heart Failure, EarlyView.
Nrf2 signalling is impaired in heart failure, contributing to oxidative stress, mitochondrial dysfunction, and ferroptosis, which drive neurohormonal activation, inflammation, and ischaemia‐reperfusion injury. This loss of Nrf2 activity exacerbates hypertension, diabetic cardiomyopathy, and cardiotoxicity, accelerating progression to overt heart ...
Emiliano Fiori, Sergio Davinelli, Armando Ferrera, Alessandro Medoro, Carlo Barsali, Allegra Battistoni, Maurizio Volterrani, Massimo Volpe, Luciano Saso, Speranza Rubattu   +9 more
wiley   +1 more source

Aortic root geometry in bicuspid aortic insufficiency versus stenosis: implications for valve repair.

European Journal of Cardio-Thoracic Surgery, 2015
T. Al-Atassi, M. Hynes, B. Sohmer, B. Lam, T. Mesana, M. Boodhwani   +5 more
semanticscholar   +1 more source

[MSB-49] Postoperative Aortic Valve Insufficiency: Outcomes of Aortic Valve Preservation in Type A Aortic Dissection

Kemal Eşref Erdoğan, Emrah Uğuz, Nur Gizem Elipek   +2 more
openalex   +2 more sources

Iatrogenic Acute Aortic Insufficiency Following Mitral Valve Replacement. [PDF]

Cureus, 2022
Alshoubi A.
europepmc   +1 more source

Use of Indicator Dilution Techniques in Measuring Combined Aortic and Mitral Insufficiency [PDF]

, 1966
Dennis A. Bloomfield, Edward J. Battersby, B. C. SINCLAIR-SMITH   +2 more
openalex   +1 more source

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

ESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra, Daniela Tomasoni, Marianna Adamo, Offer Amir, Stefan D. Anker, Antoni Bayes‐Genis, Michael Boehm, Javed Butler, Ovidiu Chioncel, Gerasimos Filippatos, Finn Gustafsson, Ewa A. Jankowska, Juan Carlos Kaski, Brenda Moura, Mark C. Petrie, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Francois Roubille, Gianluigi Savarese, Petar Seferovic, Peter van der Meer, Maurizio Volterrani, Andrew J. Coats, Vijay K. Chopra, Giuseppe Rosano   +25 more
wiley   +1 more source

Four decades of heart–lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure

ESC Heart Failure, EarlyView.
Abstract Aims Heart–lung transplantation (HLTx) remains a life‐saving intervention for patients with end‐stage cardiopulmonary failure. We retrospectively analysed long‐term HLTx outcomes at our centre to assess survival trends and evaluate the impact of evolving immunosuppressive, surgical and perioperative strategies.
L. Lily Rosenthal, Anna Maria Mühlbauer, Carola Grinninger, Nikolaus A. Haas, Heinrich Netz, Robert Dalla Pozza, Jürgen Hörer, Sebastian Michel, R. Schramm, D. Graetz, Christian Hagl   +10 more
wiley   +1 more source

Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients

Circulation: Heart Failure, 2014
U. Jorde, N. Uriel, Nadav Nahumi, D. Bejar, José González-Costello, S. Thomas, Jason Han, Kerry A. Morrison, Sophie Jones, S. Kodali, R. Hahn, Sofia Shames, M. Yuzefpolskaya, P. Colombo, H. Takayama, Yoshifumi Naka   +15 more
semanticscholar   +1 more source

Key questions about aortic insufficiency in patients with durable left ventricular assist devices. [PDF]

Front Cardiovasc Med, 2022
Calin E, Ducharme A, Carrier M, Lamarche Y, Ben Ali W, Noly PE.   +5 more
europepmc   +1 more source